GOLD SPONSORS

AUSTRALIAN COMMISSION ON SAFETY AND QUALITY IN HEALTH CARE

The Commission’s role is to lead and coordinate national improvements in the safety and quality of health care. The Commission works in partnership with the Australian Government, state and territory governments and the private sector to achieve a safe, high-quality and sustainable health system. In doing so, the Commission also works closely with patients, carers, clinicians, managers, policymakers and healthcare organisations.

Key functions of the Commission include developing national safety and quality standards, developing clinical care standards to improve the implementation of evidence-based health care, coordinating work in specific areas to improve outcomes for patients, and providing information, publications and resources about safety and quality.

GILEAD SCIENCES AUSTRALIA

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, fungal infections and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 130 people.

Pfizer

Every day, Pfizer colleagues work to provide improved health outcomes by supporting preventions, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as a World leading biopharmaceutical company, we collaborate with healthcare providers, governments and local communities to support and expand access to reliable and affordable health care for the community.

Pfizer Anti-Infectives has undertaken to prioritise research, education and drug development initiatives designed to help address the critical need for novel antimicrobial medicines, a better understanding of bacterial antibiotic resistance and projects to enhance antimicrobial stewardship. Please visit us at www.pfizer.com.au

Bronze SPONSORS

bioMerieux

bioMerieux is a world leader in the field of in vitro diagnostics and has a long standing commitment to improve public health worldwide through in-vitro diagnostics. We are present worldwide in more than 150 countries through 43 subsidiaries and distributors

bioMerieux develop tests that bring high medical value for clinical decisions in the areas of:

• infectious diseases

• cardiovascular emergencies

• targeted cancers

• Women’s Health

With a strong belief that “Diagnostics is Power – The power to save lives”, we provide diagnostic solutions that include reagents, instruments and IT solutions and services to help provide high quality, actionable laboratory results to clinicians to best diagnose, treat and manage patients at the same time improve laboratory workflow efficiency.

BD INTEGRATED DIAGNOSTIC SOLUTIONS

Transforming the diagnostic pathway from specimen collection and management to improved laboratory performance, enabling customers to deliver accurate diagnoses.

The portfolio is integrated in both clinical and lab processes and includes:

Specimen Management

Innovative solutions to acquire and transport different specimen types ensuring sample quality while improving total cost of ownership and patient convenience.

Microbiology

Transforming the microbiology laboratory with an extensive portfolio of microbiology solutions designed as integrated, end-to-end offerings, to enhance testing while streamlining workflows to improve outcomes and reduce overall costs.

Molecular and Women’s Health & Cancer

Integrated and automated tools for laboratories to analyse sequences in the genome and proteome that support infectious disease diagnosis and advance cervical cancer screening and management.

Point of Care

Rapid immunoassay and molecular platforms to drive decentralisation of care, including the latest developments for flu and COVID-19 testing.

CEPHEID

Cepheid’s GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid’s broad test portfolio spans respiratory infections, blood virology, women’s and sexual health, Tuberculosis and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company’s solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. We call this the PCRplus advantage.

MORNING TEA SPONSOR

AstraZeneca

At AstraZeneca Australia & New Zealand, we have been working to deliver life-changing medicines to patients for more than 60 years with over 800 employees across Australia and New Zealand.

Our ambition in Vaccines and Immune Therapies is to develop and deliver transformative vaccines and antibodies, providing long-lasting immunity for millions of people where the burden of disease is greatest. The pandemic tested our health systems to their limits, systems that were already straining to meet increasing population needs and bridge health inequalities. Change is needed to build healthcare provision that is both resilient and sustainable in the face of long-term stresses.

To support this and drive improvements in public health, we are investing in ground-breaking collaborations, local partnerships, commercial initiatives and advanced manufacturing. We supplied our COVID-19 vaccine at cost during the pandemic and were the first manufacturer to join COVAX, a facility working for equitable access to COVID-19 vaccines. We are also innovating across our supply chain and manufacturing processes to ensure that we are able to respond to market demand, boosting productivity when needed, while maintaining excellence in product quality and efficiency.

SPONSORS